Since NB progression may also be affected by metabolic perturbations induced by the triple treatment, we measured the plasma levels of several metabolic peptides conceivably involved in NB progression, including leptin, MIP-2, FGF-21, GM-CSF, ghrelin, IP-10, MCP-1, and PYY (Figure 5). Here, FGF21 is linked to neuroblastoma.